Panel Discussion: Novel Delivery Modalities & Gene Therapy Approaches in PKD
- Exploring gene therapy, antisense oligonucleotides, and CRISPR-based approaches
- Overcoming delivery barriers to the kidney
- Designing preclinical studies with translational relevance
- Regulatory considerations for first-in-human studies